Notices and Activity Reports

Participated in the Inaugural Conference and Symposium of the Japanese Society of Preemptive Clinical Medicine

The event was held yesterday, June 2-3, at Yumebutai on Awaji Island, The Japanese Society of Preemptive Clinical Medicine, Inc.We participated in the inaugural conference and symposium of the The main theme was “Strategies for the Cancer and Refugee Sphere. The Japan Association for Preemptive Medicine was newly established in April this year. Many of the study group’s professors were in attendance, as some of them serve on the board of directors. In the symposium, Dr. Kato, who is the executive director of the study group, gave a lecture on the “Cancer and Refugee Sphere”,Luke’s Ashiya ClinicFrom Masahiko Shirotani, Director of“Usefulness of intestinal flora transplantation (fecal flora transplantation) using special bacterial solutions.”There was a presentation on the We also presented a clinical report on intestinal flora transplantation and the water used for the bacterial solution. We are now conducting experiments on mice to study the usefulness of the bacteria solution, and we plan to report on the results at the general meeting to be held in October. This was an opportunity for many medical professionals to learn about the possibility of intestinal flora transplantation.

▼ Presentation by Dr. Shirotani

Exhibited a booth at the venue!

▼ From left: Dr. Kawai from Kawai Naika Clinic, Dr. Zen Tanaka from Tanaka Clinic,
Dr. Masayuki Holm Oe from Life Clinic and Ms. Mayumi Sakamoto from Council Member

From start to finish, the venue was filled with enthusiasm like a gathering of aspirants, bringing about a revolution in Japanese healthcare. The ever-increasing cost of medical care and the growing life expectancy of nursing care. New medical treatments and tests were introduced throughout the day. We will continue to work to gain recognition as a medical treatment that can contribute to the health of more people. Please look forward to the development of intestinal flora transplantation.

Articles about other Notices and Activity Reports

October 06, 2026

Survey Summary from the 10th Annual Academic Conference

The 10th Annual Academic Conference was held on September 27, 2026.The event was conducted in a hybrid format, both on-site and online, with close to 150 participants in total, including healthcare professionals, corporate representatives, research institution staff, and even patients, their families, and members of the general public. In this article, we share the results […]

September 28, 2026

10th Scientific Conference of the Association for Clinical Research of Fecal Microbiota Transplantation Japan [Event Report]

The Association for Clinical Research of Fecal Microbiota Transplantation Japan (General Incorporated Foundation) held its 10th Scientific Conference on Sunday, 27 September 2026. At this milestone 10th conference, we presented the latest findings and clinical data on “NanoGAS®-FMT” across a wide range of clinical fields, including cancer, gastroenterology, neurodevelopmental disorders and endoscopic examinations, for those […]

October 28, 2024

〈Clinical Trial〉Completion Report

We are pleased to report the completion of the specified clinical trial titled “Specified Clinical Trial on the Efficacy and Safety of a Novel Fecal Microbiota Transplantation Method for Autism Spectrum Disorder,” which was initiated by our research group in May 2023. This specified clinical trial is published on the jRCT (Japan Registry of Clinical […]